NewAmsterdam Pharma (NAMS) Income After Tax (2023 - 2026)
NewAmsterdam Pharma (NAMS) posted Income After Tax of -$64.14 million for Q2 2026, compared with -$17.36 million a year earlier.
Powered by 
Analysis
NewAmsterdam Pharma (NAMS) Income After Tax (2023 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Income After Tax at NewAmsterdam Pharma was -$259.5 million; for FY2025, it came in at -$203.82 million.
- In prior years, NewAmsterdam Pharma's Income After Tax was -$241.6 million in FY2024, -$176.94 million in FY2023, -$22.63 million in FY2022 and -$41.79 million in FY2021.
- Quarterly Income After Tax has run from a low of -$93.77 million in Q1 2024 to a high of -$16.65 million in Q3 2024 over five years.
- According to Business Quant data, Income After Tax for the three prior quarters was -$48.44 million (Q1 2026), -$74.92 million (Q4 2025) and -$72.01 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income After Tax (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.80 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.25 Bn |
| 10 | NewAmsterdam Pharma | 2.30 Bn | -236.30 Mn | - | -17.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -17.39 Mn |
| Jun 30, 2026 | -64.14 Mn |
| Mar 31, 2026 | -48.44 Mn |
| Dec 31, 2025 | -74.92 Mn |
| Sep 30, 2025 | -72.01 Mn |
| Jun 30, 2025 | -17.36 Mn |
| Mar 31, 2025 | -39.53 Mn |
| Dec 31, 2024 | -92.18 Mn |
| Sep 30, 2024 | -16.65 Mn |
| Jun 30, 2024 | -39.01 Mn |
| Mar 31, 2024 | -93.77 Mn |
| Dec 31, 2023 | -49.47 Mn |
| Sep 30, 2023 | -47.13 Mn |
| Jun 30, 2023 | -38.29 Mn |
| Mar 31, 2023 | -42.02 Mn |
API Access
NewAmsterdam Pharma Income After Tax API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=profit-after-tax&ticker=NAMS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "profit-after-tax", "ticker": "NAMS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=profit-after-tax&ticker=NAMS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();